Fundraising Fox

Daniel Gil

Investor

Venture Partner at Visionary Ventures

About

A pharmaceutical R&D veteran of over 30 years and current CEO of Pelage Pharmaceuticals. Formerly VP of Research Technologies and Portfolio at Allergan; holds a biology degree from Harvard and a PhD in pharmacology from the University of Pennsylvania.

Colleagues at Visionary Ventures